However, individuals with clinical KS had significantly lower mean CD4+ T cell counts and percentages than individuals without KS but with evidence of prior HHV8 exposure (i. e. HHV8-specific antibodies or detectable HHV8 DNA, Fig 1E). The gene discussed is CD4; the disease is Kaposi's sarcoma.